MedTrace Logo

Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus

NCT06161363 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2025-12-31

No results posted yet for this study

Summary

The project focuses on non-compliance in patients with systemic lupus erythematosus taking Plaquenil. More than half of patients with chronic illness are not or only poorly compliant with their treatment and lupus is one of them.

The investigators want to use an already validated existing questionnaire in English, the Morisky Medication Adherence Scale 8 (MMAS 8). These results will make it possible, after a multivariate study with reference to the gold standard which is hydroxychloroquinemia, to see which exact questions in the questionnaire can be used in general medicine practices in order to detect less or non-compliant patients as early as possible.

Conditions

  • Lupus Erythematosus

Interventions

OTHER

The Morisky Medication Adherence Scale

The Morisky Medication Adherence Scale will be completed bu the patients

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-27
Primary Completion
2024-11-16
Completion
2024-12-16

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06161363 on ClinicalTrials.gov